ATS Issues Recommendations for Noninvasive Ventilation in COPD
The American Thoracic Society presented recommendations for the use of noninvasive ventilation in patients with COPD and chronic hypercapnia.
Critical Care
Early Hydrocortisone Use in Septic Shock May Improve Outcomes
For patients with vasopressor-dependent septic shock, early hydrocortisone use is associated with improved outcomes.
Comparing Tracheostomy Tube Decannulation Protocols in Critically Ill Patients
The time to tracheostomy tube decannulation in critically ill patients was significantly shorter with a protocol based on suctioning frequency with continuous high-flow oxygen therapy vs 24-hour capping.
Tocilizumab Reduces Need for Mechanical Ventilation in COVID-19 Pneumonia Trial
Patients treated with tocilizumab were 44% less likely to progress to mechanical ventilation or death compared with placebo.
Hydrocortisone Did Not Reduce Mortality, Respiratory Support Need in COVID-19
Low-dose hydrocortisone was not associated with a significant reduction in death by day 21 of treatment compared with placebo in critically ill patients with COVID-19.
Managing Sedation, Analgesia in Critically Ill Patients Receiving Naltrexone
Researchers convened to develop recommendations on management of sedation and analgesia in critically ill patients receiving naltrexone for opioid use disorder.
Potential Role for Extracorporeal Membrane Oxygenation Support in Severe COVID-19
Critically ill patients with severe coronavirus disease 2019 may benefit from extracorporeal membrane oxygenation therapy.
COVID-19 Hospitalization Data From 14 States: 1 in 3 Youths Admitted to ICU
Investigators analyzed hospitalization data of children in 14 states and found that — although COVID-19–associated hospitalization among children is low compared with that of adults — 1 in 3 hospitalized children was admitted to an ICU.
Low Prevalence of Lung Obstruction, Restriction in COVID-19 After ICU Discharge
Researchers observed a low prevalence of lung obstruction and restriction and either mild or no cognitive impairment in patients with COVID-19 after ICU discharge.
Additional Presentations of Ready-to-Use Premixed Vancomycin Bags Approved
The new doses of Vanco Ready include 150mL, 250mL, and 350mL premixed bags containing 750mg, 1.25g, and 1.75g of vancomycin, respectively.
-
Loading...
-
Loading...
Next post in Critical Care
